Arabic Arabic English English French French German German
dark

Identification of Medicinal Products: Path to Global Implementation

FDA presents updates on the Identification of Medicinal Products (IDMP) standards development and implementation with an emphasis on international collaboration, pilot projects on substance, dosage form and pharmaceutical identification (PhPID). Also discussed is the Global Substance Registration System (GSRS) and EU Substance Registration System (SRS).
Learn more at: https://www.fda.gov/drugs/news-events-human-drugs/identification-medicinal-products-path-global-implementation-06112021-06112021
——————– 
FDA CDER’s Small Business and Industry Assistance (SBIA) educates and provides assistance in understanding the regulatory aspects of human drug products & clinical research.  

Upcoming Training – https://www.fda.gov/cdersbia   
SBIA Listserv – https://public.govdelivery.com/accounts/USFDA/subscriber/new?topic_id=USFDA_352
SBIA 2021 Playlist – https://youtube.com/playlist?list=PLey4Qe-UxcxYS1MaTusSgyifQDqdeepyD
SBIA LinkedIn – https://www.linkedin.com/showcase/cder-small-business-and-industry-assistance  
SBIA Training Resources – https://www.fda.gov/cderbsbialearn  
Twitter – https://twitter.com/FDA_Drug_Info  
Email – CDERSBIA@fda.hhs.gov  
Phone – (301) 796-6707 I (866) 405-5367

Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

Consumer Updates: Health and Safety Information You Need

Next Post

Public Meeting: Patient-Focused Drug Development for Fibromyalgia (Part 1 of 2)

Related Posts
Total
0
Share